Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and commercializing life-changing treatments
for people with serious, challenging and under-addressed disorders. The company's diverse portfolio includes four FDA-approved treatments as well as clinical
programs in multiple therapeutic areas. Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms.